POZEN (POZN) Slammed as FDA May Limit PA32540 Treatment in Post-CABG Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. ERAS
4. TREX
5. SPY
6. WFC
7. BAC
8. SPCX
9. SPRO
10. AAPL

Go back to POZEN (POZN) Slammed as FDA May Limit PA32540 Treatment in Post-CABG Patients